Open AccessMenopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy
Author(s) -
JoAnn E. Manson,
Aaron K. Aragaki,
Shari S. Bassuk,
Rowan T. Chlebowski,
Garnet L. Anderson,
Jacques E. Rossouw,
Barbara V. Howard,
Cynthia A. Thomson,
Marcia L. Stefanick,
Andrew M. Kaunitz,
Carolyn Crandall,
Charles B. Eaton,
Victor W. Henderson,
Simin Liu,
Juhua Luo,
Thomas E. Rohan,
Aladdin H. Shadyab,
Gretchen Wells,
Jean WactawskiWende,
Ross L. Prentice,
Whi Investigators
Publication year - 2019
Publication title -
annals of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.839
H-Index - 390
eISSN - 1539-3704
pISSN - 0003-4819
DOI - 10.7326/m19-0274
Subject(s) - medicine , hazard ratio , women's health initiative , oophorectomy , randomized controlled trial , hormone therapy , hysterectomy , estrogen , gynecology , breast cancer , hormone replacement therapy (female to male) , cancer , surgery , confidence interval , postmenopausal women , testosterone (patch)
Whether health outcomes of menopausal estrogen therapy differ between women with and without bilateral salpingo-oophorectomy (BSO) is unknown.